Comments
Loading...
Y-mAbs Therapeutics (YMAB) Forecast
NewsEarningsY-mAbs Therapeutics (YMAB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestY-mAbs Therapeutics (NASDAQ:YMAB) Stock Quotes, Forecast and News Summary
Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Y-mAbs Therapeutics (YMAB) stock?
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Who are Y-mAbs Therapeutics (YMAB) competitors?
There are no as such competitors for Y-mAbs Therapeutics.
What is the forecast, or price target, for Y-mAbs Therapeutics (YMAB) stock?
Y-mAbs Therapeutics has a consensus price target of $19.29.
What is the current price for Y-mAbs Therapeutics (YMAB)?
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $5.95 last updated January 30, 2025 at 4:42 AM EST.
Does Y-mAbs Therapeutics (YMAB) pay a dividend?
There are no upcoming dividends for Y-mAbs Therapeutics.
When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?
Y-mAbs Therapeutics’s Q4 earnings are confirmed for Thursday, February 27, 2025.
Is Y-mAbs Therapeutics (YMAB) going to split?
There is no upcoming split for Y-mAbs Therapeutics.
What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.